What Pharmatis does

Pharmatis is a French pharmaceutical Contract Development and Manufacturing Organization (CDMO) headquartered in Estrées-Saint-Denis (Oise), operating a single 5,000 m² GMP-certified (BPF) facility housing 15 automated production lines running seven days per week, with annual output capacity of approximately 60 million units across a portfolio of 120 product references. The company specializes in single-dose packaging of liquids, semi-liquids, gels, suspensions, and ointments, organized around four core formats: the proprietary Pharmastick® stickpack (4–15 ml, batch sizes up to 9,000 L), drinkable glass ampoules (2–10 ml), single-dose sachets, and 30–300 ml glass and PET bottles with childproof systems. Supporting these formats is a full-service CDMO offering covering formulation, pilot/validation batches (30–3,000 L), ICH stability studies, analytical method development and transfer, CTD Module 3 regulatory documentation, GMP manufacturing for human and veterinary markets, serialization and aggregation for the EU and Russian regulators, and tamper-evidence systems.

The company serves pharmaceutical, OTC, nutraceutical, medical device, and veterinary manufacturers on a direct, project-quoted B2B basis, with named enterprise clients including Biocodex, Sanofi, Ipsen, Eisai, Innothera, Negma, Subtipharm, and Gimberg. Approximately 66% of production is exported, and about 25 active client relationships are reported. Differentiation rests on first-mover status in the Pharmastick® stickpack, multi-jurisdictional regulatory credentials (ISO 14001 — first in pharma — since 1998, ISO 9001, BPF, EU serialization, Russian aggregation), and flexible batch economics enabled by automated lines running continuous production. The company is privately held, with growth capital from French private investment fund UI Investissement (2017) supporting R&D reinforcement and international expansion. Pricing is not publicly disclosed and is negotiated on a per-project basis.

Name

Pharmatis

Legal name

Pharmatis

Website

https://pharmatis.fr

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing (CDMO)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Pharmaceutical contract manufacturing
• Single-dose packaging
• Stickpack manufacturing
• Liquid formulation CDMO
• GMP pharmaceutical production

Headquarters

HQ city

Estrées-saint-denis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. CDMO Manufacturing Services: Full-service contract manufacturing for pharmaceutical, OTC, medical devices, food supplements, and veterinary products. Services span from R&D and formulation to production and logistics, providing integrated solutions under GMP conditions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharmatis is a pharmaceutical contract development and manufacturing organization (CDMO) that produces single-dose packaging formats — stickpacks (Pharmastick®), drinkable glass ampoules, liquid/gel sachets, and glass/PET bottles — for liquid and semi-liquid products destined for the Pharma, OTC, nutraceutical, medical device, and veterinary markets. The company provides full integrated services from formulation and analytical R&D through pilot and validation batches, GMP/BPF-certified production, serialization and aggregation for European and Russian regulatory compliance, and finished logistics. Manufacturing is carried out at a 5,000 m² facility in Estrées-Saint-Denis, France, using 15 automated production lines operating seven days a week.

Product overview

Pharmatis is a CDMO (Contract Development and Manufacturing Organization) specializing in single-dose, liquid, and semi-liquid pharmaceutical packaging. The company operates as a full-service provider offering integrated solutions from formulation to logistics. The product portfolio centers on four primary packaging formats: Pharmastick® (the company's pioneering stickpack brand for single-dose liquids and gels), drinkable ampoules (2-10ml glass ampoules), liquid/gel sachets (single-dose formats across 7 automated lines), and pharmaceutical bottles (30-300ml glass and PET with childproof systems). Supporting these core products are three service modules: Full Service covering R&D, analytical development, pilot/validation batches, and stability studies; Security services providing serialization, aggregation, and tamper-evidence for regulatory compliance; and Quality Control & Regulatory services with comprehensive analytical testing equipment. The company serves Pharma, OTC, medical devices, and nutraceutical markets with BPF/GMP-certified manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmastick®: Pioneer stickpack product line for single-dose liquid and semi-liquid packaging, easy-to-open ready-to-use packaging for gels, solutions, and ointments
• Pharmastick® Sachets

Products and services

• Pharmastick® Pharmastick® is Pharmatis's pioneering stickpack product — a ready-to-use, easy-to-open single-dose packaging for liquids, gels, suspensions, alcoholic solutions, and ointments. Contents range from 4 to 15 ml with commercial batch sizes up to 9,000 liters. Operated via 1 automated 5-track line and 2 automated 10-track lines. Targeted at Pharma, OTC, and nutraceutical customers.
• Ampoules buvables (Drinkable ampoules) Drinkable glass ampoules for liquid medications and dietary supplements. Automated production lines produce 2ml formats and fully automated 7ml and 10ml formats, with batch sizes up to 3,000 liters. Aimed at Pharma, OTC, and nutraceutical markets.
• Sachets liquides et gels (Liquid and gel sachets) Single-dose liquid and gel sachets in various formats for pharmaceutical and nutraceutical applications. Produced on 7 fully automated lines and 1 semi-automatic line. Targeted at Pharma, OTC, and nutraceutical customers requiring flexible single-dose unit formats.
• Flacons (Glass and PET bottles) Glass and PET pharmaceutical bottles ranging from 30ml to 300ml with childproof systems, suitable for solutions and gels. Targeted at Pharma, OTC, and nutraceutical markets requiring liquid packaging in bottle format.
• Full Service (R&D et Analytique) Full-service CDMO offering covering the entire product lifecycle from formulation to logistics. Includes bench lots (2L), pilot lots (30–500L), validation lots (500–3,000L), ICH stability studies, analytical development and transfer, and CTD Module 3 documentation. Targeted at pharmaceutical companies needing integrated development and manufacturing support.
• Sécurité - Sérialisation et Agrégation (Serialization and Aggregation services) Tamper-evidence, serialization, and aggregation services ensuring full traceability and compliance with European and Russian pharmaceutical regulations. Includes inviolability sealing and aggregation linking individual units to shipping containers. Targeted at pharmaceutical companies needing track-and-trace compliance.
• Contrôle Qualité et Règlementaire (Quality Control and Regulatory services) Quality control and regulatory compliance services including HPLC, UPLC, GC, atomic absorption spectrometry, IR spectrometry, UV-visible spectrophotometry, potentiometry, and viscometry. Covers European and international regulatory compliance. Targeted at pharmaceutical companies needing analytical release testing and regulatory support.

Quantifiable outcome

• Production capacity doubled in 10 years
• +1 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fareva: French-headquartered CDMO providing formulation, manufacturing, and packaging of pharmaceutical, cosmetic, and OTC liquids — a direct competitor in liquid/semi-liquid contract manufacturing with comparable European scale and serialization capabilities.
• Drug Plastics & Glass Co: US-based manufacturer of pharmaceutical glass and PET bottles with child-resistant packaging — directly comparable to Pharmatis's bottle line (30–300ml, childproof) for pharma and OTC liquid packaging.
• Delpharm: Major French pharmaceutical CDMO offering contract manufacturing of sterile and non-sterile liquid forms, including ampoules and bottles, for global pharma clients — directly comparable in GMP liquid manufacturing, regulatory documentation, and European customer base.
• Unither Pharmaceuticals: French CDMO specializing in single-dose liquid formulations (stickpacks, drinkable ampoules, sachets) — the closest direct competitor to Pharmatis in the unit-dose liquid CDMO niche, with overlapping formats and a similar tier-1 pharma customer base.

Broad incumbents

• Aenova Group: European CDMO offering solid, semi-solid, and liquid dosage forms for pharma and consumer health — competes with Pharmatis in liquid/semi-liquid contract manufacturing but across a broader portfolio including tablets and capsules.
• Catalent: Global CDMO with extensive sterile fill-finish, oral dose, and packaging capabilities serving large pharma customers — a broad incumbent that competes with Pharmatis on pharma packaging and serialization contracts but with significantly larger scale and dosage-form breadth.
• Recipharm: Large European CDMO with broad dosage-form coverage including sterile liquids, parenterals, and semi-solids; competes with Pharmatis for European pharma contract manufacturing but operates at much greater scale across multiple sites and dosage forms.
• Gerresheimer AG: Global primary packaging manufacturer for pharma, including glass ampoules, bottles, and plastic containers — competes with Pharmatis's ampoule and bottle lines while also supplying packaging components to broader pharma manufacturers.
• Corden Pharma: European CDMO with capabilities across peptides, injectables, and small-molecule drug product manufacturing — an established competitor for pharma liquid/parenteral contract manufacturing, though broader in scope than Pharmatis's unit-dose focus.

Emerging players

• DWK Life Sciences: Manufacturer of glass containers and ampoules for pharmaceutical and laboratory applications — overlaps with Pharmatis's drinkable ampoule production, though DWK is more component-focused than full-service CDMO.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmatis

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmatis